Inventor · disambiguated record
Kurt R. Gehlsen
Also filed as: GEHLSEN KURT R
28 granted patents·15 pending applications·290 citations·filing 1989–2025
96Inventor score
Files withMAXIM PHARM INC13RESEARCH CORPORATION TECH INC10RES CORP TECH INC3JOLLA CANCER RES FOUND2BRAMHILL DAVID1
Top patents by PatentIndex Score
43 records- 0194US9617550B2Pichia pastoris strains for producing predominantly homogeneous glycan structureRES CORP TECH INC·Filed 2013·Granted Apr 11, 2017·16 cites·14 claims
- 0290US12359211B2Pichia pastoris strains for producing predominantly homogeneous glycan structureRESEARCH CORPORATION TECH INC·Filed 2023·Granted Jul 15, 2025·0 cites·19 claims
- 0390US10329572B2Pichia pastoris strains for producing predominantly homogeneous glycan structureRESEARCH CORPORATION TECH INC·Filed 2017·Granted Jun 25, 2019·3 cites·18 claims
- 0488US10612033B2Pichia pastoris strains for producing predominantly homogeneous glycan structureRESEARCH CORPORATION TECH INC·Filed 2019·Granted Apr 7, 2020·2 cites·16 claims
- 0585US6270781B1Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitorsMAXIM PHARM INC·Filed 1999·Granted Aug 7, 2001·118 cites·9 claims
- 0685US2025304980A1Pichia pastoris strains for producing predominantly homogeneous glycan structureRESEARCH CORPORATION TECH INC·Filed 2025·Application pending·0 cites
- 0783US11220692B2Pichia pastoris strains for producing predominantly homogeneous glycan structureRESEARCH CORPORATION TECH INC·Filed 2020·Granted Jan 11, 2022·1 cites·8 claims
- 0883US6407133B2Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2001·Granted Jun 18, 2002·12 cites·7 claims
- 0981US6242473B1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 1999·Granted Jun 5, 2001·33 cites·12 claims
- 1080US11866715B2Pichia pastoris strains for producing predominantly homogeneous glycan structureRESEARCH CORPORATION TECH INC·Filed 2021·Granted Jan 9, 2024·0 cites·14 claims
- 1180US6350785B2Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitorsMAXIM PHARM INC·Filed 2001·Granted Feb 26, 2002·25 cites·24 claims
- 1278US6893633B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted May 17, 2005·8 cites·15 claims
- 1377US6790440B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted Sep 14, 2004·7 cites·9 claims
- 1475US6531120B2Ophthalmic histamine compositions and uses thereofMAXIM PHARM INC·Filed 2001·Granted Mar 11, 2003·7 cites·12 claims
- 1574US6730692B2Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2002·Granted May 4, 2004·4 cites·13 claims
- 1672US6462067B1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageMAXIM PHARM INC·Filed 2000·Granted Oct 8, 2002·3 cites·18 claims
- 1771US9603911B2Ribotoxin molecules derived from sarcin and other related fungal ribotoxinsRES CORP TECH INC·Filed 2014·Granted Mar 28, 2017·1 cites·28 claims
- 1871US6613788B1Elevation of circulating blood histamine levelsMAXIM PHARM INC·Filed 2000·Granted Sep 2, 2003·2 cites·22 claims
- 1970US6821510B2Methods and compositions for promoting the maturation of monocytesMAXIM PHARM INC·Filed 2002·Granted Nov 23, 2004·3 cites·10 claims
- 2058US2002095001A1Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitorsFiled 2002·Application pending·0 cites
- 2158US2004191239A1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageFiled 2004·Application pending·0 cites
- 2257US2005171192A1Use of histamine to treat bone diseaseFiled 2004·Application pending·0 cites
- 2356US5547936AInhibition of cell migration with synthetic peptidesJOLLA CANCER RES FOUND·Filed 1993·Granted Aug 20, 1996·13 cites·3 claims
- 2455US5180809AAdhesion receptor for laminin and its useJOLLA CANCER RES FOUND·Filed 1989·Granted Jan 19, 1993·10 cites·8 claims
- 2555US2004219153A1Synergistic tumorcidal response induced by histamineFiled 2004·Application pending·0 cites
- 2654US6071942AElevation of circulating blood histamine levelsMAXIM PHARM INC·Filed 1997·Granted Jun 6, 2000·9 cites·9 claims
- 2754US2003017145A1Treatment and prevention of reactive oxygen metabolite-mediated cellular damageFiled 2002·Application pending·0 cites
- 2853US9803210B2Fusion proteins comprising immunoglobulin constant domain-derived scaffoldsRES CORP TECH INC·Filed 2013·Granted Oct 31, 2017·0 cites·7 claims
- 2952US6498181B1Synergistic tumorcidal response induced by histamineMAXIM PHARMACEUTICALS·Filed 1999·Granted Dec 24, 2002·8 cites·1 claims
- 3052US2003228277A1Use of ROM production and release inhibitors to treat and prevent intraocular damageFiled 2003·Application pending·0 cites
- 3151US10113164B2Pichia pastoris surface display systemRESEARCH CORPORATION TECH INC·Filed 2014·Granted Oct 30, 2018·0 cites·12 claims
- 3251US2002094323A1Methods and compositions for promoting the maturation of monocytesFiled 2001·Application pending·0 cites
- 3351US2002193416A1Synergistic tumorcidal response induced by histamineFiled 2002·Application pending·0 cites
- 3450US2003149090A1Compositions for the treatment of infectious diseasesFiled 2002·Application pending·0 cites
- 3548US9976131B2Ribotoxin molecules derived from sarcin and other related fungal ribotoxinsRESEARCH CORPORATION TECH INC·Filed 2017·Granted May 22, 2018·0 cites·15 claims
- 3647US11542321B2Engineered stable CH2 polypeptidesRESEARCH CORPORATION TECH INC·Filed 2018·Granted Jan 3, 2023·0 cites·23 claims
- 3745US2004120926A1Reactive oxygen metabolite inhibitors for use in compositions and methods of treatmentFiled 2003·Application pending·0 cites
- 3842US2003039628A1Activation and protection of T-cells (CD4+ and CD8+) using an H2 receptor agonist and other T-cell activating agentsFiled 2002·Application pending·0 cites
- 3942US2006002913A1Use of histamine and related compounds to treat disorders affecting muscle functionGEHLSEN KURT R·Filed 2005·Application pending·0 cites
- 4042US2003091553A1Use of histamine to treat liver diseaseFiled 2002·Application pending·0 cites
- 4141US6221893B1Administration of histamine for therapeutic purposesMAXIM PHARM INC·Filed 1996·Granted Apr 24, 2001·5 cites·23 claims
- 4239US10829558B2Small antibody-like polypeptides that bind to EPHA2 receptorRESEARCH CORPORATION TECH INC·Filed 2015·Granted Nov 10, 2020·0 cites·27 claims
- 4336US2013189247A1Multimeric Proteins Comprising Immunoglobulin Constant DomainsBRAMHILL DAVID·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kurt R. Gehlsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →